Search

everythinglearnresearchcommunity

for

Search:↓

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

People with severe hair loss have lower zinc levels in their blood.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Machine learning can accurately identify Alopecia Areata, aiding in early detection and treatment of this hair loss condition.

Fzd2 is important for skin and hair development through various signaling ways.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

PRP is an effective and safe treatment for hair loss in women.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.